UNSPSC 85812135: Introduction of other anti-infective into nose, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other anti-infective into nose, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E09329

UNSPSC 85812135, Introduction of other anti-infective into nose, percutaneous approach, is a Commodity code with minimal recent relevance to state and local procurement activity. The code's medical procedure nomenclature does not align with the solicitations appearing under it in recent state and local contract databases.

The recent opportunities tagged to this code span diverse healthcare service categories — virtual urgent care, medical services, PACE operations, cancer registry services, occupational health, behavioral health, emergency medical services, wellness programs, and recovery audit services — none of which describe intranasal anti-infective procedures or match the procedure code's clinical scope. The issuing bodies include health plans (Inland Empire Health Plan in California), counties (DeKalb County, Georgia; Santa Clara County, California; San Mateo County, California; Jackson County, Missouri), state health authorities (Nevada), cities (Phoenix, Ocala, Atlanta), special-purpose districts (Boulder County Sheriff's Office, Ventura County), and cooperative purchasing vehicles (H-GAC, Sourcewell). The geographic spread covers California, Georgia, Nevada, Colorado, Florida, Missouri, Kansas, Texas, Illinois, New York, Oregon, and the District of Columbia, reflecting nationwide activity. However, this geographic and issuing-body diversity reflects misclassification rather than genuine procurement activity under the code — the opportunities are medical services, behavioral health treatment, staffing, and program operations that state and local entities are actively buying, but they are not purchases of intranasal anti-infective procedures. The code appears to be a taxonomy mismatch in the procurement platform's indexing system rather than an active category for state and local buyers. Business development professionals should verify whether this code is actually in use by state and local procurement offices before allocating pursuit resources; the recent opportunities suggest the code is either erroneously applied or represents a procedural service line that state and local governments do not currently solicit independently.